Argenx Se (ARGX) Non-Current Assets (2015 - 2025)

Argenx Se (ARGX) posted Non-Current Assets of $1.8 billion for Q4 2025, up 100.03% on a QoQ basis from -$5829.7 billion in Q2 2025, and up 35.18% year-over-year from $1.3 billion in Q4 2024.

Argenx Se (ARGX) Non-Current Assets (2015 - 2025) Analysis & Trends

Argenx Se's Non-Current Assets history runs 11 years deep, the most recent figure standing at $1.8 billion for Q4 2025.

  • Quarterly Non-Current Assets rose 35.18% year-over-year to $1.8 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5826.4 billion (changed N/A YoY) and the FY2025 annual result came in at $1.8 billion, up 35.18% from the prior year.
  • Non-Current Assets was $1.8 billion for Q4 2025 at Argenx Se, up from -$5829.7 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.8 billion in Q4 2025 and bottomed at -$5829.7 billion in Q2 2025.
  • A 5-year average of -$582.4 billion and a median of $389.4 million in 2022 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2021 — Non-Current Assets jumped 387.53% — and 2025, when it sank 1094330.5%.
  • Argenx Se's Non-Current Assets stood at $307.3 million in 2021, then advanced by 17.17% to $360.1 million in 2022, then increased by 16.29% to $418.7 million in 2023, then surged by 215.11% to $1.3 billion in 2024, then soared by 35.18% to $1.8 billion in 2025.
  • Business Quant data shows ARGX's Non-Current Assets at $1.8 billion in Q4 2025, -$5829.7 billion in Q2 2025, and $1.3 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 21.65 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 5.83 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 30.30 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.95 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 285.82 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 910.24 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.78 Bn
Jun 30, 2025 -5,829.73 Bn
Dec 31, 2024 1.32 Bn
Jun 30, 2024 532.77 Mn
Dec 31, 2023 418.72 Mn
Jun 30, 2023 502.28 Mn
Dec 31, 2022 360.06 Mn
Jun 30, 2022 319.95 Mn
Dec 31, 2021 307.30 Mn
Jun 30, 2021 348.36 Mn
Dec 31, 2020 216.26 Mn
Jun 30, 2020 71.45 Mn
Dec 31, 2019 66.55 Mn
Jun 30, 2019 55.35 Mn
Dec 31, 2018 6.87 Mn
Jun 30, 2018 5.08 Mn
Dec 31, 2017 4.83 Mn
Jun 30, 2017 3.93 Mn
Dec 31, 2016 4.30 Mn
Dec 31, 2015 2.00 Mn